Lv4
498 积分 2025-07-01 加入
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
6天前
已完结
Sweet’s Syndrome
20天前
已完结
Hemophagocytic Lymphohistiocytosis
1个月前
已完结
Pulmoanry sarcoidosis
1个月前
已完结
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML
6个月前
已完结
Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy
1年前
已完结
Diagnosis and Treatment of Polycythemia Vera
1年前
已关闭
Diagnosis and Treatment of Polycythemia Vera: A Review
1年前
已完结
皖公网安备34019202002308
